Cetera Investment Advisers trimmed its position in Abrdn Healthcare Investors (NYSE:HQH - Free Report) by 74.3% during the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 46,695 shares of the financial services provider's stock after selling 135,085 shares during the period. Cetera Investment Advisers owned about 0.09% of Abrdn Healthcare Investors worth $749,000 as of its most recent filing with the SEC.
Other hedge funds and other institutional investors have also made changes to their positions in the company. Kingswood Wealth Advisors LLC lifted its stake in Abrdn Healthcare Investors by 63.7% during the fourth quarter. Kingswood Wealth Advisors LLC now owns 54,531 shares of the financial services provider's stock worth $875,000 after purchasing an additional 21,212 shares during the last quarter. Absolute Investment Advisers LLC purchased a new stake in shares of Abrdn Healthcare Investors during the 4th quarter worth approximately $1,786,000. Stratos Wealth Partners LTD. bought a new position in Abrdn Healthcare Investors in the 4th quarter valued at $187,000. Wolverine Asset Management LLC bought a new stake in shares of Abrdn Healthcare Investors during the 4th quarter worth $2,196,000. Finally, Oppenheimer & Co. Inc. raised its position in Abrdn Healthcare Investors by 94.6% in the 4th quarter. Oppenheimer & Co. Inc. now owns 174,268 shares of the financial services provider's stock worth $2,797,000 after purchasing an additional 84,731 shares during the period. 32.60% of the stock is currently owned by institutional investors.
Abrdn Healthcare Investors Price Performance
Shares of NYSE HQH traded down $0.22 during midday trading on Friday, hitting $15.21. 57,210 shares of the company traded hands, compared to its average volume of 191,012. The stock has a 50-day moving average price of $15.55 and a 200 day moving average price of $16.64. Abrdn Healthcare Investors has a 12-month low of $13.77 and a 12-month high of $19.79.
Abrdn Healthcare Investors Increases Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Monday, June 30th. Stockholders of record on Thursday, May 22nd will be given a dividend of $0.54 per share. This represents a $2.16 annualized dividend and a dividend yield of 14.20%. This is an increase from Abrdn Healthcare Investors's previous quarterly dividend of $0.50. The ex-dividend date of this dividend is Thursday, May 22nd.
About Abrdn Healthcare Investors
(
Free Report)
Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries.
Read More
Before you consider abrdn Healthcare Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and abrdn Healthcare Investors wasn't on the list.
While abrdn Healthcare Investors currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
